New Drug Applications

Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran

Written by David Miller

– New PDUFA goal date scheduled for July 14, 2022, due to amendment to address pending inspection classification at third-party secondary packaging and labeling facility – – New facility has been identified and incorporated into…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]